Gentell CEO Navigates Oil Price Shock Amid Strait of Hormuz Crisis Gold and Silver Futures Maintain Weakness as Breakdown Risks Linger Jim Cramers Investing Club Highlights Diversification Beyond AI in May Monthly Meeting April Jobs Report Preview Labor Market Cooling but Resilient Economists Anticipate Oil Prices Slide Amid Hopes of Iran Strait of Hormuz Deal Rubio Warns of Alternative Measures Key Market Movers SpaceX IPO Speculation Nvidia Earnings and Bezos AI Bubble Comments Highlighted in CNBCs Morning Squawk TRMB Q1 2026 Earnings EPS Beats Estimates by 794 as Stock Edges Higher OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss QMCO Q1 2026 Earnings Adjusted EPS Surprises to the Upside Despite Stock Decline AMTM Q1 2026 Earnings EPS Beats Estimates by 26 Revenue Details Not Reported MACOM Technology Solutions MTSI Q1 2026 Earnings EPS Slightly Misses Estimates as Shares Edge Lower SREA Q1 2026 Earnings Earnings Per Share Slightly Misses Consensus Notes Edge Higher Forward Air FWRD Edges Lower in Quiet Trading Testing Key Support Zone Lionheart Holdings Unit CUBWU Holds Steady Near Support Quiet Trading Signals Consolidation Serina Therapeutics SER Slips 6 as Stock Approaches Key Support Level SHF Holdings Inc SHFS Falls Toward Support as Digital Banking Headwinds Persist Snail Inc SNAL Retreats to 092 as Selling Pressure Intensifies Yankees Consider Bold Strategic Shift as Star Slugger Faces Performance Decline CSL Q1 2026 Earnings EPS Surpasses Estimates Despite Limited Revenue Disclosure Neumora Therapeutics NMRA Slides 216 as Stock Tests Key Support Levels Tutor Perini Corporation TPC Q1 2026 Earnings EPS Surges 287 Above Estimates Stock Rises Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues AREC Q3 2025 Earnings SmallerThanExpected Loss Signals Operational Progress MSN Q1 2024 Earnings Narrowing Losses Amid Limited Revenue Disclosure Stock Surges 2026 IMNN Q1 2026 Earnings Narrowing Losses Beat Street Expectations as Pipeline Progress Continues VLRS Q1 2026 Earnings EPS Beat Provides Margin of Relief Amid Cost Pressures Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress